RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
4beta-Methyl-5-(3-hydroxyphenyl)morphan Opioid Agonist and Partial Agonist Derived from a 4beta-Methyl-5-(3-hydroxyphenyl)morphan Pure Antagonist
Carroll, F., Gichinga, M., Williams, JD., Vardy, E., Roth, BL., Mascarella, S., Thomas, J., & Navarro, H. (2013). 4beta-Methyl-5-(3-hydroxyphenyl)morphan Opioid Agonist and Partial Agonist Derived from a 4beta-Methyl-5-(3-hydroxyphenyl)morphan Pure Antagonist. Journal of Medicinal Chemistry, 56(21), 8826-8833. https://doi.org/10.1021/jm401250s
In previous studies we reported that addition of 7alpha-acylamino groups to N-phenylpropyl-4beta-methyl-5-(3-hydroxyphenyl)morphan (4) led to compounds that were pure opioid receptor antagonists. In contrast to these findings we report in this study that addition of a 7alpha-amino (5a), 7alpha-alkylamino (5b-e), or 7alpha-dialkylamino (5f-h) group to 4 leads to opioid receptor ligands with varying degrees of agonist/antagonist activity. The 7alpha-amino and 7alpha-methylamino analogues were full agonists at the mu and delta receptors and antagonists at the kappa receptor. The 7alpha-cyclopropylmethylamino analogue 5h was a full agonist at the mu receptor with weaker agonist activity at the delta and kappa receptors. Whereas the addition of a 7alpha-acylamino group to the pure nonselective opioid receptor antagonist N-phenylpropyl-4beta-methyl-5-(3-hydroxyphenyl)morphan (4) led to kappa selective pure opioid receptor antagonist, the addition of a 7alpha-amino, 7alpha-alkylamino, or 7alpha-dialkylamino group to 4 leads to opioid ligands that are largely mu or delta agonist with mixed agonist/antagonist properties
